NIDDK-Sponsored Center for Iron & Hematology Disorders at The University of Utah School of Medicine

The Center for Iron and Hematology Disorders (CIHD) at the University of Utah School of Medicine consists of three scientific core facilities which include the Mutation Generation & Detection Core, the Metabolomics Core, and the Iron & Heme Core. In addition to these Cores, there is an Enrichment Program, Internal and External Advisory Committees, and a Pilot and Feasibility program for the Center for Iron and Hematology Disorders. These cores offer many different services to a large majority of members within the CIHD as well as The University of Utah. To contact Core directors, find out services provided, and the rates of these services, click on the respective page. To find out upcoming events these Cores and programs will be providing, click on Events Calendar.

Funding announcement

The successful competitive renewal of our Center for Iron and Heme Disorders (CIHD) grant from the NIDDK contains funds to continue Pilot and Feasibility awards. We welcome P&F grants for this next fiscal year. Proposals are due August 10, 2021 and following competitive evaluations, three awards for $33,000 will be awarded September 1, 2021. The funds must be expended by July 31, 2022. The awards will be for one single year with no second-year extensions. The goals of the CIHD are to support research on molecular/cellular biological pathways involved in normal hematopoietic stem cell biology, erythroid differentiation and disease states in addition to iron and heme biology.

The stipulations for the CIHD P&F awards are as follows:

  1. CIHD members are entitled to apply with a proposal distinct from any previous CIHD proposals from past funding periods.
  2. CIHD members from outside Utah are welcome to apply if they have an active collaboration with a Utah member of the CIHD.
  3. A Principal Investigator (PI) must be a tenure track or research track faculty with an appointment of at least 0.75 FTE. Research faculty must have had a two-year residency at their institution prior to funding applications. Proposals that have previously been submitted to an extramural agency and found to be non-competitive will not be reviewed.
  4. All successful applicants for funding will be asked to present an update of their research at a spring 2022 CIHD symposium.

Checklist for submission

  1. Abstract: 1 separate page
  2. 3 pages of project description: significance, background and proposed studies
  3. Statement of relevance to our CIHD
  4. Description of CIHD cores to be utilized
  5. NIH-style biosketch
  6. Current and pending support
  7. Proposed budget and justification ($33,000 maximal budget)
  8. NIH grant submission plans

Applications should be submitted as pdf files to dennis.winge@hsc.utah.edu and john.phillips@hsc.utah.edu


The NIDDK aims to foster and support diversity amongst our researchers and trainees. Please see the attached link for more information.  link
Interested individuals should feel free to contact the NIDDK Program Director, Hematology Dr. Cindy Roy for further assistance.
Cindy N. Roy, PhD, Program Director, Hematology
Division of Kidney, Urologic and Hematologic Diseases (KUH)
NIH/NIDDK, Bethesda, MD 20817
Office: 301-594-8805; Mobile:301-356-2931; Fax: 301-480-3510
Email: cindy.roy@nih.gov   www.niddk.nih.gov